Skip to main content
. 2016 Apr 6;94(4):710–716. doi: 10.4269/ajtmh.15-0862

Table 6.

Comparison of demographic and clinical details Chromobacterium violaceum to other VACS organisms

C. violaceum Aeromonas spp.* Vibrio spp.* Shewanella spp.*
No. of bacterial isolates 28 312 71 61
Sex
 Males  (% of total) 13 (46) 203 (68) 47 (77) 51 (84)
Age
 0–15 8 (28.6) 27 (9) 8 (13) 2 (3)
 16–60 14 (50) 223 (74) 43 (70) 51 (84)
 > 60 6 (21.4) 50 (17) 10 (16) 8 (13)
Site of isolation (%)
 Skin and  soft tissue 12 (42.9) 260 (83) 52 (73) 50 (82)
 Blood 2 (7.1) 11 (3.5) 7 (9.9) 6 (9.8)
 Feces 4 (14.3) 16 (5.1) 6 (8.5) 0 (0)
 Respiratory 6 (21.4) 4 (1.3) 2 (2.8) 4 (6.6)
 Peritoneal 0 (0) 3 (1.0) 1 (1.4) 0 (0)
 Bile 0 (0) 2 (0.6) 0 (0) 0 (0)
 Bone 0 (0) 1 (0.3) 0 (0) 0 (0)
 Eye 0 (0) 6 (1.9) 1 (1.4) 1 (1.6)
 Urine 4 (14.3) 5 (1.6) 1 (1.4) 0 (0)
 Genital tract 0 (0) 3 (1.0) 0 (0) 0 (0)
 Ear 0 (0) 1 (0.3) 1 (1.4) 0 (0)
ICU admission (% of total) 7 (25) 13 (4.2) 3 (4.1) 4 (6.6)

ICU = intensive care unit; VACS = Vibrio spp., Aeromonas spp., C. violaceum, and Shewanella spp.

*

Isolate data from 2000 to 2013 inclusive, as reported by McAuliffe and others.1